HGERS
AMPH icon

Householder Group Estate & Retirement Specialist’s Amphastar Pharmaceuticals AMPH Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-91
Closed -$4.18K – 1108
2023
Q3 		$4.18K Buy
+91
New +$4.96K ﹤0.01% 971

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's AMPH Position: Q4 2023 in Review

Householder Group Estate & Retirement Specialist sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2023, closing a stake of 91 shares — an estimated $4.18K sold.

Householder Group Estate & Retirement Specialist first reported a position in AMPH in Q3 2023 and held it in 1 quarter. The position peaked at $4.18K in Q3 2023. 277 funds tracked by Wall St. Rank hold AMPH as of Q4 2023.

  • Householder Group Estate & Retirement Specialist reported no remaining Amphastar Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 91 Amphastar Pharmaceuticals shares in Q4 2023, an estimated $4.18K.
  • Householder Group Estate & Retirement Specialist first reported a position in Amphastar Pharmaceuticals in Q3 2023 and held it in 1 quarter.
  • Householder Group Estate & Retirement Specialist's Amphastar Pharmaceuticals position peaked at $4.18K in Q3 2023.
  • 277 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2023.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2023, filed 23 Jan 2024.